|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
|
HY-100014-1mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-10mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-100mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-5mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-50mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-10mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-100mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-25mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-5mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-50mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100517-1mg
|
MedChemexpress LLC
|
TP-472 [CAS 2079895-62-6]
|
|
Cancer-programmed cell death
|
|
|
HY-100536-10mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100536-100mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100536-25mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100536-5mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100536-50mg
|
MedChemexpress LLC
|
IWP-3 [CAS 687561-60-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100540-10mg
|
MedChemexpress LLC
|
Golgicide A [CAS 1139889-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100540-100mg
|
MedChemexpress LLC
|
Golgicide A [CAS 1139889-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100540-5mg
|
MedChemexpress LLC
|
Golgicide A [CAS 1139889-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100540-50mg
|
MedChemexpress LLC
|
Golgicide A [CAS 1139889-93-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100561-1g
|
MedChemexpress LLC
|
Tempol [CAS 2226-96-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100561-200mg
|
MedChemexpress LLC
|
Tempol [CAS 2226-96-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100565-1mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100565-10mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
